183 related articles for article (PubMed ID: 15882241)
21. [Quality of life of Crohn's disease patients].
Gabalec L; Bures J; Sedová M; Valenta Z
Cas Lek Cesk; 2009; 148(5):201-5. PubMed ID: 19642314
[TBL] [Abstract][Full Text] [Related]
22. The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.
Persoons P; Vermeire S; Demyttenaere K; Fischler B; Vandenberghe J; Van Oudenhove L; Pierik M; Hlavaty T; Van Assche G; Noman M; Rutgeerts P
Aliment Pharmacol Ther; 2005 Jul; 22(2):101-10. PubMed ID: 16011668
[TBL] [Abstract][Full Text] [Related]
23. Corticosteroid-associated complications in elderly Crohn's disease patients.
Akerkar GA; Peppercorn MA; Hamel MB; Parker RA
Am J Gastroenterol; 1997 Mar; 92(3):461-4. PubMed ID: 9068470
[TBL] [Abstract][Full Text] [Related]
24. Treatment of Crohn's disease with cannabis: an observational study.
Naftali T; Lev LB; Yablecovitch D; Half E; Konikoff FM
Isr Med Assoc J; 2011 Aug; 13(8):455-8. PubMed ID: 21910367
[TBL] [Abstract][Full Text] [Related]
25. Plasma citrulline concentration as a marker for disease activity in patients with Crohn's disease.
Elkhatib I; Buchman AL
J Clin Gastroenterol; 2012 Apr; 46(4):308-10. PubMed ID: 21897281
[TBL] [Abstract][Full Text] [Related]
26. Hyperhomocysteinaemia is associated with osteoporosis in patients with Crohn's disease.
Roblin X; Phelip JM; Genevois M; Ducros V; Bonaz B
Aliment Pharmacol Ther; 2007 Apr; 25(7):797-804. PubMed ID: 17373918
[TBL] [Abstract][Full Text] [Related]
27. Mild-to-moderate active luminal Crohn's disease.
Michetti P; Juillerat P; Mottet C; Pittet V; Gonvers JJ; Vader JP; Froehlich F; Felley C
Digestion; 2007; 76(2):92-8. PubMed ID: 18239399
[TBL] [Abstract][Full Text] [Related]
28. Oral butyrate for mildly to moderately active Crohn's disease.
Di Sabatino A; Morera R; Ciccocioppo R; Cazzola P; Gotti S; Tinozzi FP; Tinozzi S; Corazza GR
Aliment Pharmacol Ther; 2005 Nov; 22(9):789-94. PubMed ID: 16225487
[TBL] [Abstract][Full Text] [Related]
29. Low-intensity exercise improves quality of life in patients with Crohn's disease.
Ng V; Millard W; Lebrun C; Howard J
Clin J Sport Med; 2007 Sep; 17(5):384-8. PubMed ID: 17873551
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor-alpha haplotype is strongly associated with bone mineral density in patients with Crohn's disease.
Lee N; Fowler E; Mason S; Lincoln D; Taaffe DR; Radford-Smith G
J Gastroenterol Hepatol; 2007 Jun; 22(6):913-9. PubMed ID: 17565648
[TBL] [Abstract][Full Text] [Related]
31. Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity.
Vermeire S; Schreiber S; Sandborn WJ; Dubois C; Rutgeerts P
Clin Gastroenterol Hepatol; 2010 Apr; 8(4):357-63. PubMed ID: 20096379
[TBL] [Abstract][Full Text] [Related]
32. Long-term prognosis in Crohn's disease: factors that affect quality of life.
Canavan C; Abrams KR; Hawthorne B; Drossman D; Mayberry JF
Aliment Pharmacol Ther; 2006 Feb; 23(3):377-85. PubMed ID: 16422997
[TBL] [Abstract][Full Text] [Related]
33. Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases.
Weersma RK; Peters FT; Oostenbrug LE; van den Berg AP; van Haastert M; Ploeg RJ; Posthumus MD; Homan van der Heide JJ; Jansen PL; van Dullemen HM
Aliment Pharmacol Ther; 2004 Oct; 20(8):843-50. PubMed ID: 15479355
[TBL] [Abstract][Full Text] [Related]
34. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
[TBL] [Abstract][Full Text] [Related]
35. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
[TBL] [Abstract][Full Text] [Related]
36. Narcotic use in patients with Crohn's disease.
Koch TR; Morowitz DA
Am J Gastroenterol; 2006 Jun; 101(6):1397; author reply 1397-8. PubMed ID: 16771970
[No Abstract] [Full Text] [Related]
37. Permanent work disability in Crohn's disease.
Ananthakrishnan AN; Weber LR; Knox JF; Skaros S; Emmons J; Lundeen S; Issa M; Otterson MF; Binion DG
Am J Gastroenterol; 2008 Jan; 103(1):154-61. PubMed ID: 18076736
[TBL] [Abstract][Full Text] [Related]
38. Factors affecting recurrence in patients with Crohn's disease under nutritional therapy.
Esaki M; Matsumoto T; Nakamura S; Yada S; Fujisawa K; Jo Y; Iida M
Dis Colon Rectum; 2006 Oct; 49(10 Suppl):S68-74. PubMed ID: 17106818
[TBL] [Abstract][Full Text] [Related]
39. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
[TBL] [Abstract][Full Text] [Related]
40. The impact of increased body mass index on the clinical course of Crohn's disease.
Hass DJ; Brensinger CM; Lewis JD; Lichtenstein GR
Clin Gastroenterol Hepatol; 2006 Apr; 4(4):482-8. PubMed ID: 16616354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
